MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Healthcare Medical Devices

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

TSXV:MIR - Post by User

MedMira Inc > Rapid testing all the rage

<< Previous

Bullboard Posts

Next >>

Post by TanzaniteMotherLodeon Jan 22, 2021 4:16am

181 Views

Post# 32357129

Rapid testing all the rage

You may have already heard that Canada’s federal government approved the use of rapid testing for COVID-19. Rapid testing could mean Canadians finally return to some sort of normalcy, even with the virus still rampant throughout the country. We would still need to social distance and wear a mask etc., but testing could be huge for businesses. And that means it could also be huge for the markets.

https://www.fool.ca/2020/10/15/why-rapid-testing-could-save-the-stock-market/

<< Previous

Bullboard Posts

Next >>

5 steps to mastering risk management in the stock market